Keyphrases
Tumor Promoter
100%
K562 Leukemia Cells
100%
Erythroid
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
Megakaryoblastic
100%
Transcription Factor Complex
100%
Phorbol 12-myristate 13-acetate
63%
K562 Cells
27%
Transcription Factor
18%
Cycloheximide
18%
C-Fos
18%
First Day
18%
Days of Treatment
18%
Recombinant
9%
Protein Level
9%
Binding Site
9%
Metalloproteinases
9%
Protein Synthesis
9%
K562
9%
Enhanced Activity
9%
Activator protein-1 (AP-1)
9%
MRNA Level
9%
Gene Promoter
9%
Gene-specific
9%
Immediate-early Gene
9%
Hybrid Analysis
9%
Proteinase Inhibitor
9%
Stromelysin
9%
Protein Biosynthesis
9%
Molecular Cloning
9%
Myeloid Leukemia Cells
9%
Single Cell Protein
9%
Chronic Myeloid Leukemia
9%
Labeled Protein
9%
Collagenase
9%
Protein Secretion
9%
Northern Hybridization
9%
Sustained Activation
9%
Reporter Plasmid
9%
Responsive Element
9%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Tumor Promoter
100%
Transcription Factors
100%
Tissue Inhibitor of Metalloproteinase
100%
Erythroid Potentiating Factor
100%
Phorbol
63%
Messenger RNA
36%
Cycloheximide
18%
Binding Site
9%
Metalloproteinase
9%
Protein C Fos
9%
Stromelysin
9%
Chronic Myeloid Leukemia
9%
Protein Synthesis Inhibitor
9%
Collagenase
9%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Transcription Factors
100%
Metalloprotease Inhibitor
100%
Messenger RNA
36%
K562 Cells
27%
Protein Biosynthesis
18%
Cycloheximide
18%
Transcription
9%
Gene Promoter
9%
Molecular Cloning
9%
Protein Synthesis Inhibitor
9%
Binding Site
9%
Metalloproteinase
9%
Metalloendopeptidase
9%
Immediate Early Gene
9%
Myeloid
9%
Plasmid
9%
Protein C Fos
9%
Protein Secretion
9%
Collagenase
9%
C-Fos
9%